Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Verve Therapeutics Inc (NASDAQ: VERV) was $11.23 for the day, down -0.62% from the previous closing price of $11.3. In other words, the price has decreased by -$0.62 from its previous closing price. On the day, 3.22 million shares were traded. VERV stock price reached its highest trading level at $11.325 during the session, while it also had its lowest trading level at $11.17.
Ratios:
Our analysis of VERV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.84 and its Current Ratio is at 9.84. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
On April 08, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.Canaccord Genuity initiated its Buy rating on April 13, 2023, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 02 ’25 when Kathiresan Sekar sold 9,822 shares for $4.15 per share. The transaction valued at 40,761 led to the insider holds 346,686 shares of the business.
Nickerson Joan sold 2,777 shares of VERV for $11,525 on Apr 02 ’25. The Chief Administrative Officer now owns 17,420 shares after completing the transaction at $4.15 per share. On Apr 02 ’25, another insider, Ashe Andrew D., who serves as the insider of the company, sold 2,681 shares for $4.15 each. As a result, the insider received 11,126 and left with 348,828 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 1002975936 and an Enterprise Value of 572637568. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.79 while its Price-to-Book (P/B) ratio in mrq is 2.11. Its current Enterprise Value per Revenue stands at 9.606 whereas that against EBITDA is -2.84.
Stock Price History:
The Beta on a monthly basis for VERV is 2.17, which has changed by 1.246 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, VERV has reached a high of $11.40, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is 82.16%, while the 200-Day Moving Average is calculated to be 88.79%.
Shares Statistics:
VERV traded an average of 5.35M shares per day over the past three months and 13056960 shares per day over the past ten days. A total of 88.80M shares are outstanding, with a floating share count of 65.76M. Insiders hold about 26.23% of the company’s shares, while institutions hold 74.02% stake in the company. Shares short for VERV as of 1749772800 were 17997670 with a Short Ratio of 3.36, compared to 1747267200 on 18407439. Therefore, it implies a Short% of Shares Outstanding of 17997670 and a Short% of Float of 23.86.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
